T7Select^® 1-2a DNA

The T7Select1-2a-c vectors are protein display vectors based on bacteriophage T7. The vector displays an average of 0.1–1 copies of peptides and proteins up to 900 aa in size on the surface of the T7 capsid. Target sequences are fused to the C-terminus of the 10B capsid protein near amino acid 348. T7Select1 phage are grown on a complementing host (BLT5403) that supplies large amounts of the 10A capsid protein from a plasmid. Capsids thus contain mostly 10A protein, along with 0.1–1 copy of 10B fusion protein per virion. The linear genome of T7Select1-2a is 37,245 bp in size. Unique restriction sites are shown on the vector map (TB182).


The T7Select System is sold for research use only. Any commercial use of this Product, including drug discovery or development of commercial products, requires a commercial license from EMD Millipore Corporation. Commercial use shall include but not be limited to (1) use of the Product or its components in manufacturing; (2) use of the Product or its components to provide a service, information, or data to others in exchange for consideration; (3) use of the Product or its components (or any derivatives thereof) for therapeutic, diagnostic or prophylactic purposes (including as part of a device, chip, assay or other product); or (4) resale of the Product or its components, whether or not such Product or its components are resold for use in research. Nothing contained herein shall be deemed to represent or warrant that additional third party rights are not required for use of this Product.

NOVAGEN is a registered trademark of Merck KGaA, Darmstadt, Germany

T7SELECT is a registered trademark of Merck KGaA, Darmstadt, Germany

Toxicity: Standard Handling (A)